Company: HUM
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000049071-25-000007
Chunk: 4

Company: HUMANA INC
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 4
---
 and equity$46,479 $47,065 The accompanying notes are an integral part of the consolidated financial statements.

66

Humana Inc.

CONSOLIDATED STATEMENTS OF INCOME

 For the year ended December 31, 202420232022 (in millions, except per share results)Revenues:Premiums$112,104 $101,272 $87,712 Services4,431 4,033 4,776 Investment income1,226 1,069 382 Total revenues117,761 106,374 92,870 Operating expenses:Benefits100,664 88,394 75,690 Operating costs13,696 13,188 12,671 Depreciation and amortization839 779 709 Total operating expenses115,199 102,361 89,070 Income from operations2,562 4,013 3,800 Gain on sale of Gentiva Hospice— — (237)Interest expense660 493 401 Other expense, net181 137 68 Income before income taxes and equity in net losses1,721 3,383 3,568 Provision for income taxes413 836 762 Equity in net losses(94)(63)(4)Net income$1,214 $2,484 $2,802 Net (income) loss attributable to noncontrolling interests(7)5 4 Net income attributable to Humana$1,207 $2,489 $2,806 Basic earnings per common share$10.01 $20.09 $22.20 Diluted earnings per common share$9.98 $20.00 $22.08 

The accompanying notes are an integral part of the consolidated financial statements.

67

Humana Inc.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 For the year ended December 31, 202420232022 (in millions)Net income attributable to Humana$1,207 $2,489 $2,806 Other comprehensive (loss) income:Change in gross unrealized investment (losses) gains (62)372 (1,819)Effect of income taxes15 (85)418 Total change in unrealized investment    (losses) gains, net of tax(47)287 (1,401)Reclassification adjustment